Productivity through Innovation
Fraunhofer CMI - Center for Manufacturing Innovation
- © 2015 Fraunhofer CMI.
The Fraunhofer Center for Manufacturing Innovation (CMI) conducts advanced research and development and engineers solutions for a broad range of industries, including biotechnology, photonics, manufacturing, and renewable energy. Engineers, scientists, faculty, and students at our Center transform emerging research into viable technology solutions that meet the needs of both domestic and global clients. Our services include product and device development, high precision automation systems, and laboratory assays & instruments.
Fraunhofer CMI presents low-cost, real-time, continuous flow PCR system for pathogen detection
Fraunhofer CMI (USA) and their partners from Fraunhofer IPT (Germany), as part of the ML2 consortium, aim to create low-cost pathogen diagnostics by combining microfluidic and electronic layers into a single device.Bacterial resistance to antibiotics is escalating and represents a significant health threat to the human population.
Custom Automation for Sheet Metal Forming
Traditionally, sheet metal may be formed into various shapes by hammering the metal on various anvils. This labor intensive, physical process requires master craftsmen and is normally only suited to low volume production or prototype work. As products transition to higher volume, stamping dies are fabricated to greatly speed the process and reduce cost in quantity.
The rise of bacterial resistance intensifies the need for rapid phenotype-based antibiotic susceptibility tests (ASTs) in order to safeguard our drugs of last resort. Standard ASTs are based on bacterial growth inhibition in the presence of antibiotics that take multiple (8-24) hours to complete.
Fraunhofer CMI has developed a 3D Bioprinting System for the next Generation of "Bottom-Up" Tissue Engineering
The list of patients in dire need of organ transplants grows longer every day. Patients who are fortunate enough to find a 'match' still struggle with immunosuppressive therapy and ultimate organ failure. The goal of 3D bio printing is to precisely place cells in environments that trigger...
Over the past several decades, minimally invasive surgery has become more prevalent because it does not require major incisions to the patient, allows for quicker healing, reduces post-operative pain, and may reduce wound complications. However, in comparison to open surgery, existing laparoscopic tools still limit the surgeon's dexterity significantly.
Fraunhofer CMI, in collaboration with the Fraunhofer Center for Molecular Biotechnology (CMB) and Boston University, has developed an automatic, scalable, natural plant "factory" that can efficiently produce large quantities of medication to address potential biological threats. Located in Newark, Delaware, the facility officially became operational in April 2010...